ES367269A1 - A method for the preparation of phosphonic acid (cis-1,2-epoxipropil) and its salts and corresponding esters. (Machine-translation by Google Translate, not legally binding) - Google Patents

A method for the preparation of phosphonic acid (cis-1,2-epoxipropil) and its salts and corresponding esters. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES367269A1
ES367269A1 ES367269A ES367269A ES367269A1 ES 367269 A1 ES367269 A1 ES 367269A1 ES 367269 A ES367269 A ES 367269A ES 367269 A ES367269 A ES 367269A ES 367269 A1 ES367269 A1 ES 367269A1
Authority
ES
Spain
Prior art keywords
alkyl
acid
salt
compounds
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES367269A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES367269A1 publication Critical patent/ES367269A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505Phosphonic acids containing oxirane groups; esters thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564Three-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

(Cis-1,2-epoxypropyl)-phosphonic acid or a salt or ester thereof (I) is obtained by treating a 1,2-disubstituted n-propyl phosphonic acid or salt or ester thereof with a reagent capable of effecting epoxide ring closure, at least one of the substituents being OH or functionally equivalent oxygen-containing radical and the other of the said substituents being any leaving group that can be displaced under the reaction conditions. The starting phosphonic compound may have the formula CH 3 CHX1CHXP(O)(OR) 2 (II) wherein each R is H or a C 1 -C 5 alkyl, C 2 -C 5 alkenyl, mononuclear aryl or -aralkyl, a metal of Group Ia, IIa, Ib or IIb of the Periodic Table, an amine salt-forming cation, and X and X1 are halo, hydroxy, azido, C 1 -C 5 alkanoyloxy, trihalomethyl substituted C 1 -C 5 alkanoyloxy, C 1 -C 5 alkylsulphonyloxy, aryl (alkaryl- or aralkyl-) sulphonyloxy, tri-(C 1 -C 5 alkyl) quaternary ammonium salt-forming group, N- cycloalkyl (or N-phenyl) di-(C 1 -C 5 alkyl) quaternary ammonium salt-forming group, di- (C 1 -C 5 ) alkyl sulphonium salt-forming group, aryloxy, aralkoxy, dialkoxyphosphino, N- (alkanesulphonyl) alkylamino or N-alkarylsulphonyl cycloalkylamino with the proviso that at least one of X and X1 is hydroxy or functionally equivalent oxygen-containing radical. The ring closure may be effected by treating the starting material (which may be formed in situ) with (1) an acid, e.g. H 2 SO 4 , peracetic acid or nitrous acid with a Lewis acid such as BF 3 or P 2 O 5 or with hexafluoroacetone in a protonic acid such as a mineral acid or p-toluene sulphonic acid, (2) with a solution of a metal or metal compound capable of forming metal ions in a neutral or acidic solution, e.g. with silver acetate in a mineral acid, e.g. HCl, (3) with a base having a pH equal to or greater than 7, or (4) by passing a solution of the starting material through an ion exchange column on the basic cycle. Different optically active isomers are obtained according to the particular optically active isomer used as starting material and epoxy formation occurs with a net inversion of the configuration at the carbon atom bearing the leaving substituent X or X1. The invention is more particularly directed to the production of ( ) and (-) (cis-1,2-epoxypropyl) phosphonic acid derivatives and when the product is an ester it may be converted to the free acid which may then be converted to a salt especially an alkali metal or alkaline earth metal salt by treatment with a base. The free ( ) and (-) cis-1,2-epoxypropyl phosphonic acid and salts thereof are useful antibacterial agents and may be formulated with diluents and conventional additives. They may be administered orally in capsule or tablet form or in a liquid solution or suspension or parenterally by injection in a sterile excipient. Several methods are described for preparing various types of starting materials of Formula II. Thus, the (1-hydroxy-2-organosulphonyl. oxypropyl) phosphonic compounds may be prepared by treating a compound: wherein R1 is alkyl, aryl or aralkyl and X3 is halogen, e.g. Cl or Br, with a phosphite P(OR) 3 and then reducing the resulting intermediate CH 3 CH(OSO 2 R1)C(O)P(O)(OR) 2 with a reducing agent, e.g. NaBH 4 . Compounds of Formula II in which X1 is a dialkylsulphonium salt-forming radical may be obtained by the following reaction scheme: wherein R2 is C 1 -C 5 alkyl, R1Z is an alkyl halide and Z(-) is a halogen anion. Starting compounds in which the sulphonium radical is bonded to the 1-carbon atom may be obtained by the following reaction: wherein R2SZ is a C 1 -C 5 alkylsulphenyl halide, R2X is a C 1 -C 5 alkyl halide, R3 is C 1 -C 5 alkyl, R3COOM is a metal salt of a C 1 -C 5 alkanoic acid, X# is a halogen anion and R, R2 and Z are as defined above. Compounds of the type in which an oxygen-containing radical is bonded to the 2-C atom, e.g. as in (IIb) below may be obtained by a reaction of the type: wherein R4 is C 1 -C 5 alkyl, trihalomethyl, or trihalomethyl-substituted C 1 -C 5 alkyl. Compounds in which X is halogen in Formula II may be obtained by either (a) the following reaction: wherein R5 is a hydrocarbyl radical or an alkali metal or alkaline earth metal and wherein the N-bromo-succinimide may be replaced by other functionally equivalent halogenating agents or (b) by the following reaction sequences wherein X4 is a halogen atom, this method being particularly suitable for the preparation of the ( ) threo (1-halo-2-hydroxypropyl) phosphonic acid (IIj) which may then be converted to the (+) threo derivative (IIm) by resolution as shown. Starting compounds in which the leaving group X is a substituted amino radical may be obtained by the following reaction: wherein R6 is alkyl or mononuclear cycloalkyl, X2 is a halogenating agent, H+ is the cation derived from an acid, and the chloroform is used as reaction medium for the halogenating agent. In another method the above intermediate compound VI is converted to the compound IIp below by the following reaction: wherein M, R and R6 are as defined above and wherein other appropriate sulphonyl halides may also be used instead of the reagent shown. Compounds (II) in which the oxygen-containing radical is bonded to the 1-carbon atom may be obtained by the following reaction: with further reaction of the OH group on the 1-carbon atom with an appropriate organic acid halide if required. The starting compounds in which R is C 1 -C 5 alkyl, X is OH and X1 is tri- (C 1 - 5 alkyl) quaternary ammonium or a di- (C 1 -C 5 alkyl) sulphonium salt forming group may be prepared by the latter reaction using compounds in which X1 is NH 2 or (C 1 -C 5 alkyl) mercapto and then treating the product with a C 1 -C 5 alkyl halide. Compounds II may also be obtained by reacting a suitably substituted propionyl halide with a phosphite triester to form a (2-X1-substituted propionyl) phosphonate and then reducing the latter, e.g. with an alkali metal borohydride: Threo dimethyl - [1 - (phenylamino) - 2 - hydroxyprepyl] phosphonate is obtained by reacting cis-1-propenyl phosphonate with phenyl azide to form (1,2 - N - phenyliminopropyl) phosphonate and then treating the latter with 2N H 2 SO 4 at 40 C. Treatment of the product with methyl iodide in methanol, removal of the methanol, addition of benzene and its evaporation to azeotrope the reaction mixture to dryness, followed by further reaction with methyl iodide in benzene yields the corresponding N-phenyl dimethylammonium iodide derivative. Benzyl-2-tosyloxypropionate is obtained by reacting benzyl lactate (dissolved in benzene) with p-toluene sulphonyl chloride in the presence of pyridine and on hydrogenation over a Pd on charcoal catalyst yields 2-tosyloxypropionic acid which is then treated with thionyl chloride to form 2-tosyloxypropionyl chloride.
ES367269A 1968-05-15 1969-05-14 A method for the preparation of phosphonic acid (cis-1,2-epoxipropil) and its salts and corresponding esters. (Machine-translation by Google Translate, not legally binding) Expired ES367269A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72942468A 1968-05-15 1968-05-15
US75572968A 1968-08-27 1968-08-27
US81944769A 1969-04-25 1969-04-25

Publications (1)

Publication Number Publication Date
ES367269A1 true ES367269A1 (en) 1972-02-16

Family

ID=27419130

Family Applications (2)

Application Number Title Priority Date Filing Date
ES367269A Expired ES367269A1 (en) 1968-05-15 1969-05-14 A method for the preparation of phosphonic acid (cis-1,2-epoxipropil) and its salts and corresponding esters. (Machine-translation by Google Translate, not legally binding)
ES395161A Expired ES395161A1 (en) 1968-05-15 1971-09-16 A method for the preparation of a phosphonic acid compound. (Machine-translation by Google Translate, not legally binding)

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES395161A Expired ES395161A1 (en) 1968-05-15 1971-09-16 A method for the preparation of a phosphonic acid compound. (Machine-translation by Google Translate, not legally binding)

Country Status (15)

Country Link
JP (1) JPS4919264B1 (en)
AR (1) AR195479A1 (en)
AT (1) AT306052B (en)
BE (1) BE733050A (en)
CA (1) CA939366A (en)
CH (1) CH513924A (en)
DE (1) DE1924169C3 (en)
ES (2) ES367269A1 (en)
FI (1) FI53216C (en)
FR (1) FR2008620B1 (en)
GB (1) GB1266611A (en)
IE (1) IE32804B1 (en)
IL (1) IL32180A0 (en)
NL (1) NL6907465A (en)
YU (1) YU120469A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937367A (en) * 1987-07-15 1990-06-26 Zambon Group S.P.A. Process for the preparation of intermediates for the synthesis of fosfomycin
CN114540619B (en) * 2020-11-25 2024-02-13 厦门稀土材料研究所 Functional ionic liquid and preparation method and application thereof

Also Published As

Publication number Publication date
IL32180A0 (en) 1969-07-30
DE1924169C3 (en) 1974-02-21
CA939366A (en) 1974-01-01
FI53216C (en) 1978-03-10
NL6907465A (en) 1969-11-18
FR2008620A1 (en) 1970-01-23
ES395161A1 (en) 1974-11-16
FR2008620B1 (en) 1975-10-31
IE32804B1 (en) 1973-12-12
CH513924A (en) 1971-10-15
DE1924169A1 (en) 1970-02-05
BE733050A (en) 1969-11-14
FI53216B (en) 1977-11-30
AT306052B (en) 1973-03-26
YU120469A (en) 1979-10-31
DE1924169B2 (en) 1973-07-05
GB1266611A (en) 1972-03-15
JPS4919264B1 (en) 1974-05-16
IE32804L (en) 1969-11-15
AR195479A1 (en) 1973-10-15

Similar Documents

Publication Publication Date Title
EP0055431A1 (en) Process for the preparation of 1,5-dideoxy-1,5-imino-D-glucitol and its N-derivatives
ES250753A1 (en) Process for the preparation of o,o-dialkyl-dithiophosphoryl-fatty acid compounds and pesticidal compositions containing the same
DE1545575C2 (en) N, N'-Bis- square bracket to 3 "(3 ', 4', 5'-trimethoxybenzoyloxy) -propyl square bracket to -homopiperazine
ES367269A1 (en) A method for the preparation of phosphonic acid (cis-1,2-epoxipropil) and its salts and corresponding esters. (Machine-translation by Google Translate, not legally binding)
US3903164A (en) Pharmacodynamically active amino alkyloxim ethers
US2717268A (en) Process for preparing phenyldichloro-acetamidopropanediols
ATE59387T1 (en) 1,3-DIOXANE-4-YLALENE ACID.
US5055490A (en) Stereoisomers of benzonitrile derivatives, useful as cardiac arrhythmiac agents
ES8200689A1 (en) Acylated cephalosporin analogs, process for their preparation and pharmaceutical compositions comprising them.
US3317541A (en) Decahydroisoquinoline esters of substituted benzoic acid and methods for their preparation
US2804460A (en) Tropene derivatives
PT93675B (en) PROCESS FOR THE PREPARATION OF DERIVATIVES OF UNATURATED AMINODYCARBOXYL ACIDS, CONTAINING PHOSPHORUS
FR2570699B1 (en) NOVEL PROCESS FOR THE PREPARATION OF 4H-1,2,4-TRIAZOLE DERIVATIVES, NOVEL TRIAZOLES THUS OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES367096A1 (en) (1,2-epoxypropyl)phosphonous acid derivatives
US3168514A (en) Process for the preparation of aziridine phosphoryldifluorides
GB1061425A (en) New benzofuran derivatives and process for preparing the same
US3201405A (en) Pharmacologically active derivatives of nu-methyl-isonipecotic acid
US2668855A (en) Alkylene-bis(oxyalkylene-ammonium) compounds
Alfer'Ev et al. Reactions of vinylidenediphosphonic acid with nucleophiles. 4. Addition of amino acids, diastereotopy of phosphorus atoms in the addition products
CH513849A (en) Pyrroline cpds hypoglycaemics anti-diabetics
FI844184A0 (en) ISOKINOLINDERIVAT OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
US3097211A (en) Quaternary ammonium salts of nu-tertiaryamino-alkyl-tertiary-amino-low-er-alkanamides
US3124593A (en) Pharmacologically active z
US3017423A (en) Organic compounds and process
SU539520A3 (en) The method of obtaining pyrrolyl compounds or their salts